Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection

  • Eugene Kroon
  • , Suthat Chottanapund
  • , Supranee Buranapraditkun
  • , Carlo Sacdalan
  • , Donn J. Colby
  • , Nitiya Chomchey
  • , Peeriya Prueksakaew
  • , Suteeraporn Pinyakorn
  • , Rapee Trichavaroj
  • , Sandhya Vasan
  • , Sopark Manasnayakorn
  • , Cavan Reilly
  • , Erika Helgeson
  • , Jodi Anderson
  • , Caitlin David
  • , Jacob Zulk
  • , Mark De Souza
  • , Sodsai Tovanabutra
  • , Alexandra Schuetz
  • , Merlin L. Robb
  • Daniel C. Douek, Nittaya Phanuphak, Ashley Haase, Jintanat Ananworanich, Timothy W. Schacker
  • Institute of HIV Research and Innovation
  • King Chulalongkorn Memorial Hospital
  • Walter Reed Army Institute of Research
  • Inc.
  • Armed Forces Research Institute of Medical Sciences, Thailand
  • Bamrasnaradura Infectious Disease Institute
  • University of Minnesota Twin Cities
  • University of Minnesota Medical School
  • National Institutes of Health (NIH)

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

8 Zitate (Scopus)

Abstract

Starting antiretroviral therapy (ART) in Fiebig 1 acute HIV infection limits the size of viral reservoirs in lymphoid tissues, but does not impact time to virus rebound during a treatment interruption. To better understand why the reduced reservoir size did not increase the time to rebound we measured the frequency and location of HIV RNA+ cells in lymph nodes from participants in the RV254 acute infection cohort. HIV RNA+ cells were detected more frequently and in greater numbers when ART was initiated in Fiebig 1 compared to later Fiebig stages and were localized to the T-cell zone compared to the B-cell follicle with treatment in later Fiebig stages. Variability of virus production in people treated during acute infection suggests that the balance between virus-producing cells and the immune response to clear infected cells rapidly evolves during the earliest stages of infection. Clinical Trials Registration: NCT02919306.

OriginalspracheEnglisch
Seiten (von - bis)2167-2175
Seitenumfang9
FachzeitschriftJournal of Infectious Diseases
Jahrgang225
Ausgabenummer12
DOIs
PublikationsstatusVeröffentlicht - 15 Juni 2022
Extern publiziertJa

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren